Aligos Therapeutics, Inc. (ALGS) vs MDxHealth S.A. (MDXH)

A side-by-side comparison of Aligos Therapeutics, Inc. and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGS vs MDXH

growth of $100 · dividends reinvested · last 5y
ALGS -98.6% (-57.6%/yr)MDXH -95.0% (-45.1%/yr)MDXH compounded faster over this window
020406080100Start $10020222023202420252026$1$5
ALGS MDXH

ALGS vs MDXH: by the numbers

  • •ALGS is the larger company ($33M vs $31M market cap).
  • •Both run net losses; MDXH's is the smaller (-31.07% vs -241.01% net margin).
  • •MDXH grew revenue faster over the past five years (42.35% vs -15.85% CAGR).

Metrics side by side

Valuation

MetricALGSMDXH
P/S ratio1.06N/A
P/B ratio1.05N/A

Profitability

MetricALGSMDXH
Gross margin57.46%59.74%
Operating margin-4024.93%-14.28%
Net margin-241.01%-31.07%
ROE-238.24%N/A
ROIC-207.97%-15.35%

Growth (annualized)

MetricALGSMDXH
Revenue CAGR (5Y)-15.85%42.35%
Total return CAGR (5Y)-57.15%N/A

Frequently asked

Which has grown faster, ALGS or MDXH?
Over the past five years, MDXH grew revenue faster — ALGS at a -15.85% CAGR versus MDXH at 42.35%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.